{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:37:03Z","timestamp":1785584223547,"version":"3.56.0"},"reference-count":224,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijantimicag.2025.107643","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:20:38Z","timestamp":1759990838000},"page":"107643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The evolving threat of drug-resistant malaria in a globalized world"],"prefix":"10.1016","volume":"66","author":[{"given":"Shruti","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6795-7718","authenticated-orcid":false,"given":"Ashutosh","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107643_bib0001","article-title":"Portrait of a serial killer","author":"Whitfield","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0002","unstructured":"World malaria report 2024: addressing inequity in the global malaria response, 11 December 2024, Global report. https:\/\/www.who.int\/publications\/i\/item\/9789240104440."},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40101-020-00251-9","article-title":"Plasmodium-a brief introduction to the parasites causing human malaria and their basic biology","volume":"40","author":"Sato","year":"2021","journal-title":"J Physiol Anthropol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0004","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.2147\/IDR.S279433","article-title":"Antimalarial drug resistance and novel targets for antimalarial drug discovery","volume":"13","author":"Shibeshi","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2022.102193","article-title":"Plasmodium falciparum resistance to artemisinin-based combination therapies","volume":"69","author":"Ward","year":"2022","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0006","article-title":"Evolutionary biology of antimalarial drug resistance: understanding of the evolutionary dynamics","volume":"104","author":"Igwe","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0075","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1128\/AAC.02472-14","article-title":"Polymorphisms in Pfmdr1, Pfcrt, and Pfnhe1 genes are associated with reduced in vitro activities of quinine in Plasmodium falciparum isolates from Western Kenya","volume":"58","author":"Cheruiyot","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0147","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.2147\/DDDT.S403672","article-title":"Antimalarial drug resistance: a brief history of its spread in Indonesia","volume":"17","author":"Fitri","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0181","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","article-title":"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria","volume":"10","author":"Achan","year":"2011","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0061","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1097-2765(05)00077-8","article-title":"Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance","volume":"6","author":"Fidock","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0182","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1056\/NEJM200101253440403","article-title":"A molecular marker for chloroquine-resistant falciparum malaria","volume":"344","author":"Djimd\u00e9","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0183","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12936-022-04328-x","article-title":"Molecular surveillance for anti-malarial drug resistance and genetic diversity of Plasmodium falciparum after chloroquine and sulfadoxine-pyrimethamine withdrawal in Quibdo, Colombia, 2018","volume":"21","author":"Guerra","year":"2022","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0184","first-page":"115","article-title":"Introducing new antimalarial analogues of chloroquine and amodiaquine: a narrative review","volume":"42","author":"Parhizgar","year":"2017","journal-title":"Iran J Med Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/1475-2875-8-289","article-title":"Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base","volume":"8","author":"Bouchaud","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0186","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1086\/507115","article-title":"Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin","volume":"194","author":"Sidhu","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0094","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"The Lancet"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0187","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0169-4758(95)80201-0","article-title":"Mefloquine resistance in Plasmodium falciparum","volume":"11","author":"Mockenhaupt","year":"1995","journal-title":"Parasitol Today"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0188","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4269\/ajtmh.22-0128","article-title":"Malaria in 2022: challenges and progress","volume":"106","author":"Rosenthal","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0189","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12936-023-04644-w","article-title":"Therapeutic efficacy of artesunate\u2013amodiaquine and artemether\u2013lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance","volume":"22","author":"Issa","year":"2023","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0190","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1473-3099(23)00502-9","article-title":"Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study","volume":"24","author":"Florimond","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0191","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/infdis\/jiq024","article-title":"Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax","volume":"203","author":"Imwong","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0192","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1073\/pnas.87.8.3018","article-title":"Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria","volume":"87","author":"Peterson","year":"1990","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0193","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.94.25.13944","article-title":"Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum","volume":"94","author":"Triglia","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0136","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.parint.2014.09.011","article-title":"Direct evidence for the atovaquone action on the Plasmodium cytochrome bc 1 complex","volume":"64","author":"Siregar","year":"2015","journal-title":"Parasitol Int"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0077","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0194","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12936-022-04101-0","article-title":"Efficacy and safety of dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax malaria in Papua and Sumatra, Indonesia","volume":"21","author":"Asih","year":"2022","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0007","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpddr.2019.10.001","article-title":"Profiles of kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance","volume":"11","author":"Chhibber-Goel","year":"2019","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0008","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","article-title":"The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong Subregion: a molecular epidemiology observational study","volume":"17","author":"Imwong","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.668574","article-title":"Chloroquine and sulfadoxine\u2014pyrimethamine resistance in sub-Saharan Africa\u2014a review","volume":"12","author":"Roux","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4269\/ajtmh.1961.10.5","article-title":"Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine","volume":"10","author":"Moore","year":"1961","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2018.00014","article-title":"The One Health concept: 10 years old and a long road ahead","volume":"5","author":"Destoumieux-Garz\u00f3n","year":"2018","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0012","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.2174\/0929867331666230807151708","article-title":"Drug repurposing against novel therapeutic targets in Plasmodium falciparum for malaria: the computational perspective","volume":"31","author":"Rai","year":"2023","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0013","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","article-title":"Antimalarial drug discovery: progress and approaches","volume":"22","author":"Siqueira-Neto","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0014","series-title":"Plasmodium species drug resistance. IntechOpen","article-title":"Malaria: introductory concepts, resistance issues and current medicines","author":"Nureye","year":"2021"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14787210.2021.1962291","article-title":"Current and emerging strategies to combat antimalarial resistance","volume":"20","author":"Rasmussen","year":"2022","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0016","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.parint.2009.04.004","article-title":"Spread and evolution of Plasmodium falciparum drug resistance","volume":"58","author":"Mita","year":"2009","journal-title":"Parasitol Int"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0017","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/med.21975","article-title":"Chemo-proteomics in antimalarial target identification and engagement","volume":"43","author":"Bailey","year":"2023","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0018","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1080\/21645515.2019.1669415","article-title":"RTS,S\/AS01 vaccine (Mosquirix\u2122): an overview","volume":"16","author":"Laurens","year":"2020","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0019","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S1473-3099(23)00209-8","article-title":"Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial","volume":"23","author":"Ogutu","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117339","article-title":"Recent developments in antimalarial drug discovery","volume":"88-89","author":"Umumararungu","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0021","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-3305-3-5","article-title":"History of the discovery of the malaria parasites and their vectors","volume":"3","author":"Cox","year":"2010","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0022","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev.micro.091208.073403","article-title":"Malaria parasite development in the mosquito and infection of the mammalian host","volume":"63","author":"Aly","year":"2009","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.877907","article-title":"Gametogenesis in plasmodium: delving deeper to connect the dots","volume":"12","author":"Dash","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0031182097008895","article-title":"The roles of temperature, pH and mosquito factors as triggers of male and female gametogenesis of Plasmodium berghei in vitro","volume":"115","author":"Billker","year":"1997","journal-title":"Parasitology"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0025","doi-asserted-by":"crossref","first-page":"12003","DOI":"10.1074\/jbc.273.20.12003","article-title":"Xanthurenic acid induces gametogenesis in plasmodium, the malaria parasite","volume":"273","author":"Garcia","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0026","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1126\/science.291.5501.141","article-title":"Migration of Plasmodium sporozoites through cells before infection","volume":"291","author":"Mota","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0027","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.ento.43.1.519","article-title":"Malaria parasite development in mosquitoes","volume":"43","author":"Beier","year":"1998","journal-title":"Annu Rev Entomol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001169","article-title":"The activities of current antimalarial drugs on the life cycle stages of plasmodium: a comparative study with human and rodent parasites","volume":"9","author":"Delves","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0029","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1462-5822.2006.00778.x","article-title":"Getting infectious: formation and maturation of plasmodium sporozoites in the anopheles vector","volume":"8","author":"Matuschewski","year":"2006","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41579-019-0306-2","article-title":"Plasmodium asexual growth and sexual development in the haematopoietic niche of the host","volume":"18","author":"Venugopal","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0031","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0377-1237(02)80136-8","article-title":"Resistant malaria: current concepts and therapeutic strategies","volume":"58","author":"Kalra","year":"2002","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0032","series-title":"Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010\u20132019)","year":"2020"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0033","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1128\/CMR.17.1.235-254.2004","article-title":"History, dynamics, and public health importance of malaria parasite resistance","volume":"17","author":"Talisuna","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0034","doi-asserted-by":"crossref","first-page":"1044.5","DOI":"10.1136\/bmj.330.7499.1044-d","article-title":"WHO combats counterfeit malaria drugs in Asia","volume":"330","author":"Parry","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0035","unstructured":"National Center for Vector Borne Diseases Control (NCVBDC). Drug resistance. National Center for Vector Borne Diseases Control (NCVBDC), (n.d.), New Delhi. https:\/\/ncvbdc.mohfw.gov.in\/index1.php?lang=1&level=1&sublinkid=5811&lid=3799 (accessed July 16, 2024)."},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0195","doi-asserted-by":"crossref","first-page":"8298","DOI":"10.1073\/pnas.1205651109","article-title":"Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria","volume":"109","author":"Biagini","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0196","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijpddr.2021.09.005","article-title":"Lumefantrine attenuates Plasmodium falciparum artemisinin resistance during the early ring stage","volume":"17","author":"K\u00fcmpornsin","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0197","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpddr.2021.06.003","article-title":"Mefloquine as a prophylaxis for malaria needs to be revisited","volume":"17","author":"Ahmad","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0198","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/jiw128","article-title":"Piperaquine monotherapy of drug-susceptible Plasmodium falciparum infection results in rapid clearance of parasitemia but is followed by the appearance of gametocytemia","volume":"214","author":"Pasay","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0199","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1093\/jac\/dkad260","article-title":"Pyronaridine: a review of its clinical pharmacology in the treatment of malaria","volume":"78","author":"Chu","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1475-2875-11-270","article-title":"Review of pyronaridine anti-malarial properties and product characteristics","volume":"11","author":"Croft","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0201","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s40265-016-0572-5","article-title":"Naphthoquine: an emerging candidate for artemisinin combination therapy","volume":"76","author":"Moore","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0202","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/acs.biochem.9b01105","article-title":"Tafenoquine: a step toward malaria elimination: published as part of the Biochemistry series \u201cBiochemistry to Bedside\u201d","volume":"59","author":"Lu","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0203","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101908","article-title":"Efficacy and safety of tafenoquine for malaria chemoprophylaxis (1998-2020): a systematic review and meta-analysis","volume":"39","author":"Maier","year":"2021","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0204","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-13-418","article-title":"Primaquine: the risks and the benefits","volume":"13","author":"Ashley","year":"2014","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.redox.2015.10.008","article-title":"The antimalarial drug primaquine targets Fe\u2013S cluster proteins and yeast respiratory growth","volume":"7","author":"Lal\u00e8ve","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0206","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1038\/ncomms5029","article-title":"Structural analysis of atovaquone-inhibited cytochrome bc1 complex reveals the molecular basis of antimalarial drug action","volume":"5","author":"Birth","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0207","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2958.1999.01515.x","article-title":"Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites","volume":"33","author":"Srivastava","year":"1999","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0208","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1535-7163.MCT-18-0936","article-title":"Antimalarial drug pyrimethamine plays a dual role in antitumor proliferation and metastasis through targeting DHFR and TP","volume":"18","author":"Liu","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2007.03.009","article-title":"Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro","volume":"154","author":"Sandefur","year":"2007","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7883\/yoken1952.49.1","article-title":"In vitro selection of Plasmodium falciparum lines resistant to dihydrofolate-reductase inhibitors and cross resistance studies","volume":"49","author":"Bhasin","year":"1996","journal-title":"Jpn J Med Sci Biol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0211","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1073\/pnas.94.20.10931","article-title":"Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil","volume":"94","author":"Fidock","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0212","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1093\/emboj\/17.14.3807","article-title":"Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria","volume":"17","author":"Triglia","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0213","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.35.2.267","article-title":"Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs","volume":"35","author":"Zhang","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0141","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/antiox10121872","article-title":"Reactive oxygen species as the brainbox in malaria treatment","volume":"10","author":"Egwu","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0214","doi-asserted-by":"crossref","first-page":"e9582","DOI":"10.1371\/journal.pone.0009582","article-title":"Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation","volume":"5","author":"Wang","year":"2010","journal-title":"PLOS ONE"},{"issue":"6","key":"10.1016\/j.ijantimicag.2025.107643_bib0215","article-title":"Artemether for severe malaria","volume":"6","author":"Esu","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0216","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/AAC.03663-14","article-title":"Antimalarial action of artesunate involves DNA damage mediated by reactive oxygen species","volume":"59","author":"Gopalakrishnan","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0217","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0140-6736(24)00048-5","article-title":"Dihydroartemisinin\u2013piperaquine for prevention of malaria in pregnant women living with HIV","volume":"403","author":"Kamya","year":"2024","journal-title":"The Lancet"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0218","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1063407","article-title":"Targeting malaria parasites with novel derivatives of azithromycin","volume":"12","author":"Burns","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0219","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24427","article-title":"Mechanism of action, resistance, synergism, and clinical implications of azithromycin","volume":"36","author":"Heidary","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0220","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12936-015-0980-0","article-title":"Tetracyclines in malaria","volume":"14","author":"Gaillard","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0221","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4269\/ajtmh.2011.10-0285","article-title":"Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis","volume":"84","author":"Magill","year":"2011","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0222","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/424603","article-title":"Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria","volume":"190","author":"Borrmann","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0036","series-title":"Infectious diseases","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.113193","article-title":"Antimalarial drugs with quinoline nucleus and analogs","author":"Ursul Jean-Paul N\u2019guessan","year":"2024"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0037","series-title":"Encyclopedia of malaria","first-page":"1","article-title":"Antifolate drugs","author":"Yuthavong","year":"2013"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0038","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2229-5070.175081","article-title":"Antimalarial drug resistance: an overview","volume":"6","author":"Antony","year":"2016","journal-title":"Trop Parasitol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0039","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/QCO.0000000000000766","article-title":"Artemisinin and multidrug-resistant Plasmodium falciparum \u2013 a threat for malaria control and elimination","volume":"34","author":"Dhorda","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0040","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"Eastman","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0041","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jpha.2020.07.005","article-title":"Protecting future antimalarials from the trap of resistance: lessons from artemisinin-based combination therapy (ACT) failures","volume":"11","author":"Erhunse","year":"2021","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0042","series-title":"Antimicrobial drug resistance","first-page":"629","article-title":"Mechanisms of antimalarial drug resistance","author":"Biagini","year":"2017"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0043","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s00436-020-06786-1","article-title":"Enhancing the antimalarial activity of artesunate","volume":"119","author":"Adebayo","year":"2020","journal-title":"Parasitol Res"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0044","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1586\/eri.09.68","article-title":"Discovery, mechanisms of action and combination therapy of artemisinin","volume":"7","author":"Cui","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12936-024-04844-y","article-title":"Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts","volume":"23","author":"Kokori","year":"2024","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0046","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1128\/AAC.00471-09","article-title":"Evaluation of artemisone combinations in Aotus monkeys infected with Plasmodium falciparum","volume":"53","author":"Obaldia","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0047","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/molecules26041008","article-title":"Nopol-based quinoline derivatives as antiplasmodial agents","volume":"26","author":"Nyamwihura","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0048","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1021\/acs.accounts.1c00154","article-title":"Heme detoxification in the malaria parasite: a target for antimalarial drug development","volume":"54","author":"De Villiers","year":"2021","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0049","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/cb4008953","article-title":"Quinine dimers are potent inhibitors of the Plasmodium falciparum chloroquine resistance transporter and are active against quinoline-resistant P. falciparum","volume":"9","author":"Hrycyna","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0050","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1073\/pnas.88.11.4786","article-title":"Chloroquine inhibits heme-dependent protein synthesis in Plasmodium falciparum","volume":"88","author":"Surolia","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0051","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1054\/drup.2002.0234","article-title":"Chloroquine resistance and the pH of the malaria parasite\u2019s digestive vacuole","volume":"4","author":"Kirk","year":"2001","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0052","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1038\/s41598-020-61181-1","article-title":"Structural and evolutionary analyses of the Plasmodium falciparum chloroquine resistance transporter","volume":"10","author":"Copp\u00e9e","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0053","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2174\/1386207325666210924104036","article-title":"Hemozoin (beta-hematin) formation inhibitors: promising target for the development of new antimalarials: current update and future prospect","volume":"25","author":"Mali","year":"2022","journal-title":"Comb Chem High Throughput Screen"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0054","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1073\/pnas.1501023112","article-title":"Mechanisms of hematin crystallization and inhibition by the antimalarial drug chloroquine","volume":"112","author":"Olafson","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0055","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/s41564-023-01377-z","article-title":"Chloroquine resistance evolution in Plasmodium falciparum is mediated by the putative amino acid transporter AAT1","volume":"8","author":"Amambua-Ngwa","year":"2023","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0056","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1038\/s41467-023-39969-2","article-title":"pH-dependence of the Plasmodium falciparum chloroquine resistance transporter is linked to the transport cycle","volume":"14","author":"Berger","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0057","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.pt.2012.08.002","article-title":"PfCRT and its role in antimalarial drug resistance","volume":"28","author":"Ecker","year":"2012","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0058","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pt.2007.04.013","article-title":"Is PfCRT a channel or a carrier? Two competing models explaining chloroquine resistance in Plasmodium falciparum","volume":"23","author":"Sanchez","year":"2007","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0059","doi-asserted-by":"crossref","first-page":"27910","DOI":"10.1074\/jbc.M304193200","article-title":"The digestive food vacuole of the malaria parasite is a dynamic intracellular Ca2+ store","volume":"278","author":"Biagini","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0060","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/0006-2952(86)90668-4","article-title":"Uptake of [3H]chloroquine by drug-sensitive and -resistant strains of the human malaria parasite Plasmodium falciparum","volume":"35","author":"Geary","year":"1986","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0062","doi-asserted-by":"crossref","first-page":"1363969","DOI":"10.3389\/fmala.2024.1363969","article-title":"Antimalarial drug resistance profiling of Plasmodium falciparum infections in India using Ion Torrent deep sequencing","volume":"2","author":"Kale","year":"2024","journal-title":"Front Malar"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0063","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1471-4922(02)02365-6","article-title":"The pH of the Plasmodium falciparum digestive vacuole: holy grail or dead-end trail?","volume":"18","author":"Spiller","year":"2002","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0064","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12936-023-04645-9","article-title":"Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso","volume":"22","author":"Tarama","year":"2023","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0065","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","article-title":"Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations","volume":"298","author":"Sidhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0066","doi-asserted-by":"crossref","first-page":"12689","DOI":"10.1073\/pnas.221440898","article-title":"Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America","volume":"98","author":"Mehlotra","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0067","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12936-024-04896-0","article-title":"Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021","volume":"23","author":"Bakari","year":"2024","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0068","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1128\/AAC.47.11.3500-3505.2003","article-title":"pfcrt allelic types with two novel amino acid mutations in chloroquine-resistant Plasmodium falciparum isolates from the Philippines","volume":"47","author":"Chen","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0069","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/345255a0","article-title":"Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum","volume":"345","author":"Foote","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0070","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1038\/sj.emboj.7600681","article-title":"A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance","volume":"24","author":"Lakshmanan","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0071","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01832-23","article-title":"Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered Plasmodium falciparum physiology","volume":"15","author":"Hagenah","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0072","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-3156.2005.01514.x","article-title":"Falciparum malaria in the north of Laos: the occurrence and implications of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT","volume":"10","author":"Dittrich","year":"2005","journal-title":"Trop Med Int Health TM IH"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0073","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12936-021-03657-7","article-title":"Surveillance of Plasmodium falciparum pfcrt haplotypes in southwestern Uganda by high-resolution melt analysis","volume":"20","author":"Kassaza","year":"2021","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0074","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nature00813","article-title":"Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum","volume":"418","author":"Wootton","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0076","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1475-2875-11-292","article-title":"A framework for assessing the risk of resistance for anti-malarials in development","volume":"11","author":"Ding","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0078","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0035-9203(83)90112-8","article-title":"Chloroquine resistant Plasmodium falciparum on the island of Flores, Indonesia","volume":"77","author":"Smrkovski","year":"1983","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0079","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1475-2875-11-16","article-title":"Mutant pfcrt \u201cSVMNT\u201d haplotype and wild type pfmdr1 \u201cN86\u201d are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure","volume":"11","author":"Mallick","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0080","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00019-19","article-title":"Plasmodium genomics and genetics: new insights into malaria pathogenesis, drug resistance, epidemiology, and evolution","volume":"32","author":"Su","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0081","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.759422","article-title":"Plasmodium falciparum multidrug resistance proteins (pfMRPs)","volume":"12","author":"Gil","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0082","series-title":"Plasmodium species drug resistance","article-title":"P. falciparum and its molecular markers of resistance to antimalarial drugs","author":"Hodoameda","year":"2021"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001616","article-title":"Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT","volume":"20","author":"Shafik","year":"2022","journal-title":"PLOS Biol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0084","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/AAC.00091-09","article-title":"Polymorphism in PfMRP1 (Plasmodium falciparum multidrug resistance protein 1) amino acid 1466 associated with resistance to sulfadoxine-pyrimethamine treatment","volume":"53","author":"Dahlstr\u00f6m","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0085","series-title":"Plasmodium species drug resistance. IntechOpen","article-title":"falciparum and its molecular markers of resistance to antimalarial drugs","author":"Hodoameda","year":"2021"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0086","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4269\/ajtmh.2010.09-0327","article-title":"Association of microsatellite variations of Plasmodium falciparum Na+\/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa","volume":"82","author":"Bras","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0087","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1073\/pnas.022630099","article-title":"Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine","volume":"99","author":"Banerjee","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0088","doi-asserted-by":"crossref","DOI":"10.2174\/0115680266348099250108065838","article-title":"Targeting malaria\u2019s Achilles\u2019 heels: a review of plasmodium life cycle vulnerabilities for drug discovery","volume":"25","author":"Shukla","year":"2025","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0089","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype\u2013phenotype association study","volume":"17","author":"Amato","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0090","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1038\/s41467-018-04104-z","article-title":"Plasmepsin II\u2013III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum","volume":"9","author":"Bopp","year":"2018","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.ijantimicag.2025.107643_bib0091","article-title":"A Plasmodium falciparum genetic cross reveals the contributions of pfcrt and plasmepsin II\/III to piperaquine drug resistance","volume":"15","author":"Kane","year":"2023","journal-title":"Microbial genetics"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0092","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12936-019-2756-4","article-title":"African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker","volume":"18","author":"Leroy","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0093","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025619","article-title":"Antimalarial drug resistance: a threat to malaria elimination","volume":"7","author":"Menard","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0095","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219905120","article-title":"The structure of Plasmodium falciparum multidrug resistance protein 1 reveals an N-terminal regulatory domain","volume":"120","author":"Si","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0096","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12936-015-0791-3","article-title":"Monitoring PfMDR1 transport in Plasmodium falciparum","volume":"14","author":"Reiling","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0097","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35002615","article-title":"Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum","volume":"403","author":"Reed","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0098","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.759422","article-title":"Plasmodium falciparum multidrug resistance proteins (pfMRPs)","volume":"12","author":"Gil","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0099","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029044","article-title":"Oral pigmentation as an adverse effect of chloroquine and hydroxychloroquine use: a scoping review","volume":"101","author":"Silva","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/1475-2875-12-377","article-title":"Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy","volume":"12","author":"Duah","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0101","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.actatropica.2005.04.008","article-title":"Contribution of the pfmdr1 gene to antimalarial drug-resistance","volume":"94","author":"Duraisingh","year":"2005","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0102","article-title":"Role of different Pfcrt and Pfmdr-1 mutations in conferring resistance to antimalaria drugs in Plasmodium falciparum","volume":"2014","author":"Ibraheem","year":"2014","journal-title":"Malar Res Treat"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0103","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/febs.14127","article-title":"Combating multidrug-resistant Plasmodium falciparum malaria","volume":"284","author":"Thu","year":"2017","journal-title":"FEBS J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0104","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0105","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1475-2875-11-7","article-title":"Polymorphisms of the pfmdr1 but not the pfnhe-1 gene is associated with in vitro quinine sensitivity in Thai isolates of Plasmodium falciparum","volume":"11","author":"Poyomtip","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0106","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1475-2875-9-247","article-title":"Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations","volume":"9","author":"Sridaran","year":"2010","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0107","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jac\/dkl104","article-title":"The past, present and future of antifolates in the treatment of Plasmodium falciparum infection","volume":"57","author":"Nzila","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0108","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12936-020-03454-8","article-title":"Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H","volume":"19","author":"Pacheco","year":"2020","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0109","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","article-title":"Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria","volume":"85","author":"Peterson","year":"1988","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pt.2005.04.002","article-title":"Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy","volume":"21","author":"Nzila","year":"2005","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0111","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3184\/003685002783238906","article-title":"Resistance to antifolates in Plasmodium falciparum, the causative agent of tropical malaria","volume":"85","author":"Warhurst","year":"2002","journal-title":"Sci Prog"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0112","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.673194","article-title":"High frequency mutations in pfdhfr and pfdhps of Plasmodium falciparum in response to sulfadoxine-pyrimethamine: a cross-sectional survey in returning Chinese migrants from Africa","volume":"11","author":"Yan","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0113","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.actatropica.2005.04.002","article-title":"Exploring the folate pathway in Plasmodium falciparum","volume":"94","author":"Hyde","year":"2005","journal-title":"Acta Trop"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0114","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.molbiopara.2010.03.012","article-title":"Characterisation of the bifunctional dihydrofolate synthase\u2013folylpolyglutamate synthase from Plasmodium falciparum; a potential novel target for antimalarial antifolate inhibition","volume":"172","author":"Wang","year":"2010","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0115","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ijpara.2020.12.002","article-title":"Transgenic pyrimethamine-resistant Plasmodium falciparum reveals transmission-blocking potency of P218, a novel antifolate candidate drug","volume":"51","author":"Posayapisit","year":"2021","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0116","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.1365-2958.1997.2821646.x","article-title":"Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization","volume":"23","author":"Wang","year":"1997","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0117","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijpara.2020.12.011","article-title":"Geographical spread and structural basis of sulfadoxine-pyrimethamine drug-resistant malaria parasites","volume":"51","author":"Chaturvedi","year":"2021","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0118","doi-asserted-by":"crossref","first-page":"18796","DOI":"10.1073\/pnas.1116162108","article-title":"Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes","volume":"108","author":"Mharakurwa","year":"2011","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0119","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1126\/science.1098876","article-title":"Intercontinental spread of pyrimethamine-resistant malaria","volume":"305","author":"Roper","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2165\/11203910-000000000-00000","article-title":"Dihydroartemisinin\/piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malaria","volume":"72","author":"Keating","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0121","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40249-020-00712-4","article-title":"High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos, Nigeria","volume":"9","author":"Quan","year":"2020","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0122","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1186\/s12936-018-2597-6","article-title":"Origins and spread of novel genetic variants of sulfadoxine\u2013pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia","volume":"17","author":"Basuki","year":"2018","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0123","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.673194","article-title":"High frequency mutations in pfdhfr and pfdhps of Plasmodium falciparum in response to sulfadoxine-pyrimethamine: a cross-sectional survey in returning Chinese migrants from Africa","volume":"11","author":"Yan","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0124","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/AAC.00301-12","article-title":"Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil","volume":"56","author":"Vanichtanankul","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0125","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.ijid.2009.11.035","article-title":"High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine\u2013pyrimethamine","volume":"14","author":"Zakeri","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0126","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1073\/pnas.94.4.1124","article-title":"Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase","volume":"94","author":"Sirawaraporn","year":"1997","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0127","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nyas.12662","article-title":"The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations","volume":"1342","author":"Heinberg","year":"2015","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0128","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204871","article-title":"Amplification of GTP-cyclohydrolase 1 gene in Plasmodium falciparum isolates with the quadruple mutant of dihydrofolate reductase and dihydropteroate synthase genes in Ghana","volume":"13","author":"Osei","year":"2018","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009268","article-title":"Genetic diversity of the Plasmodium falciparum GTP-cyclohydrolase 1, dihydrofolate reductase and dihydropteroate synthetase genes reveals new insights into sulfadoxine-pyrimethamine antimalarial drug resistance","volume":"16","author":"Turkiewicz","year":"2020","journal-title":"PLOS Genet"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2165\/00063030-200317001-00006","article-title":"Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malaria","volume":"17","author":"Kain","year":"2003","journal-title":"BioDrugs"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0131","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0377-1237(08)80067-6","article-title":"Atovaquone\/proguanil: a new drug combination to combat malaria","volume":"64","author":"Mustafa","year":"2008","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0132","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.3390\/ijms22042138","article-title":"Decoding the molecular effects of atovaquone linked resistant mutations on Plasmodium falciparum Cytb-ISP complex in the phospholipid bilayer membrane","volume":"22","author":"Chebon-Bore","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0133","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/AAC.01532-06","article-title":"First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America","volume":"51","author":"Legrand","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0134","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1128\/AAC.01532-06","article-title":"First case of emergence of atovaquone resistance in Plasmodium falciparum during second-line atovaquone-proguanil treatment in South America","volume":"51","author":"Legrand","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0135","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1074\/jbc.M111.324319","article-title":"Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression","volume":"287","author":"Fisher","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0137","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/AAC.44.8.2100-2108.2000","article-title":"Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site","volume":"44","author":"Korsinczky","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"issue":"17","key":"10.1016\/j.ijantimicag.2025.107643_bib0138","doi-asserted-by":"crossref","first-page":"9239","DOI":"10.3390\/ijms25179239","article-title":"Plasmodium falciparum mitochondrial complex III, the target of atovaquone, is essential for progression to the transmissible sexual stages","volume":"25","author":"Sheokand","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0139","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1128\/AAC.00937-10","article-title":"Mitochondrial electron transport inhibition and viability of intraerythrocytic Plasmodium falciparum","volume":"54","author":"Painter","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0140","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1002\/cmdc.201200383","article-title":"Interactions between artemisinins and other antimalarial drugs in relation to the co-factor model \u2013 a unifying proposal for drug action","volume":"7","author":"Haynes","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib225","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/cmdc.200700108","article-title":"The Fe2+-mediated decomposition, PfATP6 binding, and antimalarial activities of artemisone and other artemisinins: the unlikelihood of C-centered radicals as bioactive intermediates","volume":"2","author":"Haynes","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib226","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/jac\/dkt486","article-title":"Rapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potential","volume":"69","author":"Antoine","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0142","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1021\/acsinfecdis.9b00527","article-title":"Plasmodium falciparum artemisinin resistance: the effect of heme, protein damage, and parasite cell stress response","volume":"6","author":"Rosenthal","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0143","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0144","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0145","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.768182","article-title":"Oxidative stress and pathogenesis in malaria","volume":"11","author":"Vasquez","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0146","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00444","article-title":"Iron promotes dihydroartemisinin cytotoxicity via ROS production and blockade of autophagic flux via lysosomal damage in osteosarcoma","volume":"11","author":"Shen","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0148","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12936-019-2916-6","article-title":"Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?","volume":"18","author":"Foguim Tsombeng","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0149","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jgar.2021.09.001","article-title":"New insights into the spread of resistance to artemisinin and its analogues","volume":"27","author":"Noreen","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0150","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41467-020-20805-w","article-title":"Artemisinin-resistant K13 mutations rewire Plasmodium falciparum\u2019s intra-erythrocytic metabolic program to enhance survival","volume":"12","author":"Mok","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0151","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0152","article-title":"Ring-stage growth arrest: metabolic basis of artemisinin tolerance in Plasmodium falciparum","volume":"26","author":"Yu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0153","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12936-019-2701-6","article-title":"K13-propeller gene polymorphisms in Plasmodium falciparum parasite population in malaria affected countries: a systematic review of prevalence and risk factors","volume":"18","author":"Ocan","year":"2019","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0154","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12936-018-2329-y","article-title":"A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants","volume":"17","author":"Vachot-Gan\u00e9e","year":"2018","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40794-016-0027-8","article-title":"The threat of antimalarial drug resistance","volume":"2","author":"Hanboonkunupakarn","year":"2016","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0156","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jmii.2019.07.006","article-title":"Importance of kelch 13 C580Y mutation in the studies of artemisinin resistance in Plasmodium falciparum in Greater Mekong Subregion","volume":"53","author":"Zaw","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0157","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1128\/AAC.00121-10","article-title":"Investigations into the role of the Plasmodium falciparum SERCA (PfATP6) L263E mutation in artemisinin action and resistance","volume":"54","author":"Valderramos","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0158","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1475-2875-11-111","article-title":"Pfatp6 molecular profile of Plasmodium falciparum isolates in the western Brazilian Amazon","volume":"11","author":"Brasil","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0159","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02079-21","article-title":"Selective inhibition of Plasmodium falciparum ATPase 6 by artemisinins and identification of new classes of inhibitors after expression in yeast","volume":"66","author":"Moore","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpddr.2021.05.007","article-title":"Plasmodium falciparum resistance to ACTs: emergence, mechanisms, and outlook","volume":"16","author":"Siddiqui","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0161","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0162","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1016\/S1473-3099(24)00141-5","article-title":"The emergence of artemisinin partial resistance in Africa: how do we respond?","volume":"24","author":"Rosenthal","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0163","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpddr.2023.05.003","article-title":"Genomic analysis of Indian isolates of Plasmodium falciparum: implications for drug resistance and virulence factors","volume":"22","author":"Choubey","year":"2023","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0164","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51015","article-title":"Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance","volume":"9","author":"Mathieu","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12936-024-04855-9","article-title":"Epigenetic regulation as a therapeutic target in the malaria parasite Plasmodium falciparum","volume":"23","author":"Reyser","year":"2024","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0166","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1128\/EC.00036-10","article-title":"Chromatin-mediated epigenetic regulation in the malaria parasite Plasmodium falciparum","volume":"9","author":"Cui","year":"2010","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0167","article-title":"Malaria epigenetics, cold spring harb","volume":"7","author":"Cort\u00e9s","year":"2017","journal-title":"Perspect Med"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0168","article-title":"Understanding the interplay of malarial pathogenesis, host immune response and oxidative stress: implications for disease progression and therapeutic strategies","volume":"5","author":"Buthelezi","year":"2025","journal-title":"Asp Mol Med"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0169","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJMp1108322","article-title":"The threat of artemisinin-resistant malaria","volume":"365","author":"Dondorp","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0170","author":"van Wyk"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0171","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12639-021-01425-7","article-title":"An analysis of Plasmodium falciparum-K13 mutations in India","volume":"46","author":"Murmu","year":"2022","journal-title":"J Parasit Dis Off Organ Indian Soc Parasitol"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0172","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12936-020-03446-8","article-title":"Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991-2019","volume":"19","author":"Rathmes","year":"2020","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0173","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0174","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/QCO.0b013e328332c4a7","article-title":"Global resistance surveillance: ensuring antimalarial efficacy in the future","volume":"22","author":"Guerin","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0175","unstructured":"Strategy to respond to antimalarial drug resistance in Africa, (n.d.). https:\/\/www.who.int\/publications\/i\/item\/9789240060265 (accessed July 16, 2024)."},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0176","series-title":"Malaria prevention, treatment, and control strategies","year":"2011"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0177","unstructured":"Malaria control strategiese: National Center for Vector Borne Diseases Control (NCVBDC), (n.d.). https:\/\/ncvbdc.mohfw.gov.in\/index4.php?lang=1&level=0&linkid=421&lid=3707 (accessed July 16, 2024)."},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0178","unstructured":"Tackling emerging antimalarial drug resistance in Africa, (n.d.). https:\/\/www.who.int\/news\/item\/18-11-2022-tackling-emerging-antimalarial-drug-resistance-in-africa (accessed July 16, 2024)."},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0179","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0169-4758(96)10055-7","article-title":"Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria","volume":"12","author":"White","year":"1996","journal-title":"Parasitol Today"},{"key":"10.1016\/j.ijantimicag.2025.107643_bib0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12936-020-03576-z","article-title":"Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians","volume":"20","author":"Mahamar","year":"2021","journal-title":"Malar J"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925001980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T23:11:27Z","timestamp":1775517087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925001980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":224,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0924857925001980"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107643","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolving threat of drug-resistant malaria in a globalized world","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107643"}}